sub:assertion {
d:DB00679 v:identifier "DB00679" ;
v:namespace "drugbank" ;
v:uri "http://bio2rdf.org/drugbank:DB00679" ;
v:x-identifiers.org <
http://identifiers.org/drugbank/DB00679> ;
dv:drugbank-id "APRD00596" , "DB00679" ;
dv:x-atc <
http://bio2rdf.org/atc:N05AC02> ;
dv:x-cas <
http://bio2rdf.org/cas:50-52-2> ;
dv:x-chebi <
http://bio2rdf.org/chebi:9566> ;
dv:x-chemspider <
http://bio2rdf.org/chemspider:5253> ;
dv:x-dpd <
http://bio2rdf.org/dpd:360244> ;
dv:x-gtp <
http://bio2rdf.org/gtp:100> ;
dv:x-iuphar <
http://bio2rdf.org/iuphar:100> ;
dv:x-kegg <
http://bio2rdf.org/kegg:D00373> ;
dv:x-ndc <
http://bio2rdf.org/ndc:0378-0612-01> ;
dv:x-pharmgkb <
http://bio2rdf.org/pharmgkb:PA451666> ;
dv:x-pubchemcompound <
http://bio2rdf.org/pubchem.compound:5452> ;
dv:x-pubchemsubstance <
http://bio2rdf.org/pubchem.substance:46509070> ;
dv:x-wikipedia <
http://bio2rdf.org/wikipedia:Thioridazine> ;
dct:description "A phenothiazine antipsychotic used in the management of psychoses, including schizophrenia, and in the control of severely disturbed or agitated behavior. It has little antiemetic activity. Thioridazine has a higher incidence of antimuscarinic effects, but a lower incidence of extrapyramidal symptoms, than chlorpromazine. (From Martindale, The Extra Pharmacopoeia, 30th ed, p618)"@en ;
dct:identifier "drugbank:DB00679" ;
dct:title "Thioridazine"@en ;
a dv:Drug ;
rdfs:label "Thioridazine [drugbank:DB00679]"@en ;
rdfs:seeAlso <
http://www.drugbank.ca/drugs/DB00679> , <
http://www.drugs.com/cdi/thioridazine.html> , <
http://www.rxlist.com/cgi/generic3/thioridazine.htm> .
}